Elaziğ Mental Health And Diseases Hospital
Clinical trials sponsored by Elaziğ Mental Health And Diseases Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Cannabis use may alter psychosis severity in methamphetamine users Results expected Sep 2026 (estimated)
- New study investigates 'Sluggish cognitive Tempo' in FND patients Results expected Dec 2026 (estimated)
- Family ties: could Parents' personalities hold clues to mood disorder risks? Results expected Dec 2026 (estimated)
-
Scientists hunt for blood clues to bipolar disorder
Knowledge-focused CompletedThis study looked at two specific proteins in the blood of people with bipolar disorder during a manic episode and compared them to healthy volunteers. The goal was to see if these proteins, which are linked to inflammation and brain cell communication, could help explain the con…
Sponsor: Elazığ Mental Health and Diseases Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists investigate enzyme link to panic disorder
Knowledge-focused CompletedThis study looked at levels of a specific enzyme, α-N-acetylgalactosaminidase, in the blood of people with panic disorder who had never taken medication. Researchers compared these levels to healthy individuals and checked for connections with symptom severity and inflammation. T…
Sponsor: Elazığ Mental Health and Diseases Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Blood enzyme may reveal hidden clues in schizoaffective disorder
Knowledge-focused CompletedThis study examines whether levels of a blood enzyme called α-N-acetylgalactosaminidase differ between people with schizoaffective disorder during acute episodes and those in remission, compared to healthy individuals. The goal is to better understand the biological processes beh…
Sponsor: Elazığ Mental Health and Diseases Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Blood test clues for schizophrenia?
Knowledge-focused CompletedThis study measured levels of two proteins, LRFN5 and OLFM4, in the blood of 60 people — some with schizophrenia and some healthy. The goal was to see if these markers are linked to symptoms and inflammation. The study was observational, meaning it did not test any treatment.
Sponsor: Elazığ Mental Health and Diseases Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Blood enzyme may signal psychosis risk in meth users
Knowledge-focused CompletedThis study measured a specific enzyme in the blood of 93 people to see if it is linked to psychotic symptoms in methamphetamine users. Participants included people with methamphetamine use disorder, those with methamphetamine-induced psychosis, and healthy volunteers. The goal wa…
Sponsor: Elazığ Mental Health and Diseases Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC